Ignite Creation Date:
2025-12-25 @ 1:45 AM
Ignite Modification Date:
2026-03-02 @ 6:43 PM
Study NCT ID:
NCT03684694
Status:
TERMINATED
Last Update Posted:
2024-02-06
First Post:
2018-09-11
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Safety and Efficacy Study of Loncastuximab Tesirine + Ibrutinib in Diffuse Large B-Cell or Mantle Cell Lymphoma
Sponsor:
ADC Therapeutics S.A.
Organization: